Rajya Sabha MP Dr Kanimozhi NVN Somu has raised concerns about the rising number of dubious drug trials in India, highlighting the potential risks to patient safety and the erosion of trust in healthcare professionals. She has pledged to bring the issue to the attention of the Union Health Minister, citing a recent report by the Ethical Committee of National Institute of Virology (NIV) and concerns over oversight and quality control of clinical trials.